Dr. Eunice S. Wang

Dr. Eunice S. Wang, MD, is a nationally recognized hematologic oncologist and physician-scientist who serves as Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center and Professor of Oncology at the State University of New York at Buffalo. She received her medical degree from the Keck School of Medicine at the University of Southern California, completed her residency in internal medicine at Massachusetts General Hospital, and pursued fellowship training in hematology and oncology at Memorial Sloan Kettering Cancer Center. Board-certified in both hematology and medical oncology, Dr. Wang offers advanced, patient-centered care for individuals with acute leukemias, myeloproliferative neoplasms, and other complex blood cancers.

Dr. Wang is widely known for her pioneering work in translational leukemia research and for leading early-phase and investigator-initiated clinical trials. Her research explores novel targeted therapies, immune-based treatments, and the biology of the leukemia microenvironment, with a strong focus on drug resistance and disease relapse. She has contributed to the development of several promising therapeutic strategies and has authored numerous peer-reviewed publications and book chapters that inform current standards in leukemia care. Her leadership in national research efforts has positioned her as a key contributor to advancing leukemia therapeutics and precision medicine.

Beyond her clinical and research excellence, Dr. Wang is an esteemed mentor and educator, actively involved in the training of future oncologists and hematologists. She holds leadership positions in several national oncology working groups and advisory committees, including the National Cancer Institute’s Leukemia Steering Committee. Committed to bridging cutting-edge science with compassionate care, Dr. Wang continues to drive forward innovation in hematologic malignancy treatment and to improve outcomes for patients affected by blood cancers.